BioSig Technologies, Inc. NASDAQ:BSGM

Founder-led company

BioSig Technologies stock price today

$4.875
+3.39
+229.39%
Financial Health
0
1
2
3
4
5
6
7
8
9

BioSig Technologies stock price monthly change

+252.38%
month

BioSig Technologies stock price quarterly change

+252.38%
quarter

BioSig Technologies stock price yearly change

+203.09%
year

BioSig Technologies key metrics

Market Cap
22.66M
Enterprise value
47.74M
P/E
-1.78
EV/Sales
158.10
EV/EBITDA
-1.16
Price/Sales
158.10
Price/Book
152551.13
PEG ratio
-0.05
EPS
-3.23
Revenue
N/A
EBITDA
-23.95M
Income
-25.11M
Revenue Q/Q
180%
Revenue Y/Y
-90.45%
Profit margin
-13573.84%
Oper. margin
-13591.39%
Gross margin
81.13%
EBIT margin
-13591.39%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

BioSig Technologies stock price history

BioSig Technologies stock forecast

BioSig Technologies financial statements

BioSig Technologies, Inc. (NASDAQ:BSGM): Profit margin
Jun 2023 0 -11.09M
Sep 2023 1K -4.56M -456900%
Dec 2023 12K -6.04M -50408.33%
Mar 2024 14K -3.40M -24300%
BioSig Technologies, Inc. (NASDAQ:BSGM): Analyst Estimates
Mar 2024 14K -3.40M -24300%
Sep 2025 300K -3.25M -1084.8%
Oct 2025 100K -2.56M -2562.63%
Dec 2025 200K -985.62K -492.81%
  • Analysts Price target

  • Financials & Ratios estimates

BioSig Technologies, Inc. (NASDAQ:BSGM): Earnings per share (EPS)
2022-08-15 -0.19 -0.15
2022-11-14 -0.14 -0.14
2023-03-13 -0.11 -0.16431
2023-05-15 -0.1 -0.12
0%
Yield TTM
BioSig Technologies, Inc. (NASDAQ:BSGM): Payout ratio
Payout ratio 0%
BioSig Technologies, Inc. (NASDAQ:BSGM): Dividend Yield
2019 0.33%
2020 0.17%
2021 0.01%
2022 0.05%
2023 0.03%
BioSig Technologies, Inc. (NASDAQ:BSGM): Debt to assets
Jun 2023 4050000 3.61M 89.23%
Sep 2023 3154000 4.10M 130.12%
Dec 2023 1798000 4.68M 260.57%
Mar 2024 1589000 5.79M 364.51%
BioSig Technologies, Inc. (NASDAQ:BSGM): Cash Flow
Jun 2023 -4.89M -77K 4.81M
Sep 2023 -3.82M -60K 3.02M
Dec 2023 -2.94M -4K 2.74M
Mar 2024 -1.31M 0 1.54M

BioSig Technologies alternative data

BioSig Technologies, Inc. (NASDAQ:BSGM): Employee count
Aug 2023 47
Sep 2023 47
Oct 2023 47
Nov 2023 47
Dec 2023 47
Jan 2024 47
Feb 2024 47
Mar 2024 47
Apr 2024 47
May 2024 4
Jun 2024 4
Jul 2024 4

BioSig Technologies other data

6.59% -5.71%
of BSGM is owned by hedge funds
2.29M -1.99M
shares is hold by hedge funds

BioSig Technologies, Inc. (NASDAQ:BSGM): Insider trades (number of shares)
Period Buy Sel
Aug 2022 134776 0
Sep 2022 105681 0
Feb 2023 349323 0
May 2023 8000 0
Jun 2023 26200 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
LONDONER KENNETH L director, officer: Chief Execut..
Common Stock 10,000 $1.24 $12,400
Purchase
LONDONER KENNETH L director, officer: Chief Execut..
Common Stock 2,000 $1.22 $2,440
Purchase
LONDONER KENNETH L director, officer: Chief Execut..
Common Stock 600 $1.23 $738
Purchase
LONDONER KENNETH L director, officer: Chief Execut..
Common Stock 3,000 $1.26 $3,780
Purchase
LONDONER KENNETH L director, officer: Chief Execut..
Common Stock 2,000 $1.1 $2,200
Purchase
LONDONER KENNETH L director, officer: Chief Execut..
Common Stock 2,000 $1.22 $2,440
Purchase
LONDONER KENNETH L director, officer: Chief Execut..
Common Stock 2,000 $1.2 $2,400
Purchase
LONDONER KENNETH L director, officer: Chief Execut..
Common Stock 1,000 $1.32 $1,320
Purchase
LONDONER KENNETH L director, officer: Chief Execut..
Common Stock 3,000 $1.37 $4,110
Purchase
LONDONER KENNETH L director, officer: Chief Execut..
Common Stock 200 $1.43 $286
Patent
Application
Filling date: 2 Feb 2022 Issue date: 18 Aug 2022
Application
Filling date: 13 Apr 2022 Issue date: 11 Aug 2022
Grant
Filling date: 25 Sep 2019 Issue date: 10 May 2022
Application
Filling date: 16 Sep 2021 Issue date: 14 Apr 2022
Application
Filling date: 25 Aug 2021 Issue date: 3 Mar 2022
Grant
Filling date: 6 Nov 2020 Issue date: 1 Mar 2022
Application
Filling date: 7 Aug 2020 Issue date: 10 Feb 2022
Grant
Filling date: 22 Dec 2020 Issue date: 25 Jan 2022
Application
Filling date: 26 Apr 2021 Issue date: 11 Nov 2021
Grant
Filling date: 8 Oct 2020 Issue date: 21 Sep 2021
Insider Compensation
Mr. Kenneth L. Londoner M.B.A., MBA (1968) Founder, Chief Executive Officer & Executive Chairman
$1,200,000
Wednesday, 13 November 2024
globenewswire.com
Tuesday, 22 October 2024
globenewswire.com
Wednesday, 31 July 2024
globenewswire.com
Monday, 10 June 2024
globenewswire.com
Thursday, 30 May 2024
globenewswire.com
Tuesday, 21 May 2024
globenewswire.com
Friday, 3 May 2024
globenewswire.com
Tuesday, 30 April 2024
globenewswire.com
Thursday, 4 April 2024
globenewswire.com
Tuesday, 20 February 2024
globenewswire.com
Tuesday, 6 February 2024
globenewswire.com
Wednesday, 31 January 2024
globenewswire.com
Tuesday, 30 January 2024
globenewswire.com
Friday, 25 August 2023
Zacks Investment Research
Thursday, 20 July 2023
InvestorPlace
Thursday, 29 June 2023
Zacks Investment Research
Saturday, 11 February 2023
PennyStocks
Thursday, 6 October 2022
PennyStocks
Thursday, 8 September 2022
Zacks Investment Research
Benzinga
Thursday, 1 September 2022
Benzinga
Thursday, 7 July 2022
Proactive Investors
Thursday, 30 June 2022
Proactive Investors
Friday, 24 June 2022
Proactive Investors
Wednesday, 22 June 2022
Proactive Investors
Tuesday, 14 June 2022
Seeking Alpha
Thursday, 26 May 2022
Proactive Investors
Monday, 23 May 2022
Proactive Investors
Wednesday, 11 May 2022
Proactive Investors
Tuesday, 19 April 2022
GlobeNewsWire
  • What's the price of BioSig Technologies stock today?

    One share of BioSig Technologies stock can currently be purchased for approximately $4.88.

  • When is BioSig Technologies's next earnings date?

    Unfortunately, BioSig Technologies's (BSGM) next earnings date is currently unknown.

  • Does BioSig Technologies pay dividends?

    No, BioSig Technologies does not pay dividends.

  • How much money does BioSig Technologies make?

    BioSig Technologies has a market capitalization of 22.66M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 93.71% to 18K US dollars. BioSig Technologies made a loss 29.04M US dollars in net income (profit) last year or -$0.12 on an earnings per share basis.

  • What is BioSig Technologies's stock symbol?

    BioSig Technologies, Inc. is traded on the NASDAQ under the ticker symbol "BSGM".

  • What is BioSig Technologies's primary industry?

    Company operates in the Healthcare sector and Medical - Devices industry.

  • How do i buy shares of BioSig Technologies?

    Shares of BioSig Technologies can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are BioSig Technologies's key executives?

    BioSig Technologies's management team includes the following people:

    • Mr. Kenneth L. Londoner M.B.A., MBA Founder, Chief Executive Officer & Executive Chairman(age: 57, pay: $1,200,000)
  • Is BioSig Technologies founder-led company?

    Yes, BioSig Technologies is a company led by its founder Mr. Kenneth L. Londoner M.B.A., MBA.

  • How many employees does BioSig Technologies have?

    As Jul 2024, BioSig Technologies employs 4 workers, which is 91% less then previous quarter.

  • When BioSig Technologies went public?

    BioSig Technologies, Inc. is publicly traded company for more then 10 years since IPO on 31 Oct 2014.

  • What is BioSig Technologies's official website?

    The official website for BioSig Technologies is biosig.com.

  • Where are BioSig Technologies's headquarters?

    BioSig Technologies is headquartered at 55 Greens Farms Road, Westport, CT.

  • How can i contact BioSig Technologies?

    BioSig Technologies's mailing address is 55 Greens Farms Road, Westport, CT and company can be reached via phone at +20 3 4095444.

BioSig Technologies company profile:

BioSig Technologies, Inc.

biosig.com
Exchange:

NASDAQ

Full time employees:

4

Industry:

Medical - Devices

Sector:

Healthcare

BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial fibrillation, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.

55 Greens Farms Road
Westport, CT 06880

CIK: 0001530766
ISIN: US09073N3008
CUSIP: 09073N201